Related references
Note: Only part of the references are listed.MHC class I transactivator NLRC5 in host immunity, cancer and beyond
Steven X. Cho et al.
IMMUNOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy et al.
FRONTIERS IN IMMUNOLOGY (2021)
Metastatic melanoma
Ragini R. Kudchadkar et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
NLRC5: new cancer buster?
Feng Tang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
Large-scale public data reuse to model immunotherapy response and resistance
Jingxin Fu et al.
GENOME MEDICINE (2020)
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H. Lee et al.
NATURE COMMUNICATIONS (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide et al.
CANCER CELL (2019)
NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma
Qin Wang et al.
CANCER LETTERS (2019)
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Gregor Sturm et al.
BIOINFORMATICS (2019)
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy
Paola Queirolo et al.
SEMINARS IN CANCER BIOLOGY (2019)
Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT
Michael Chopin et al.
IMMUNITY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis
Rongbin Zheng et al.
NUCLEIC ACIDS RESEARCH (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
TLRs/NLRs: Shaping the landscape of host immunity
Komal Dolasia et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)
Emerging biomarkers for cancer immunotherapy in melanoma
Margaret L. Axelrod et al.
SEMINARS IN CANCER BIOLOGY (2018)
The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
Natalia Aptsiauri et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
ETS transcription factor family member GABPA contributes to vitamin D receptor target gene regulation
Sabine Seuter et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
High Expression of NLRC5 is associated with prognosis of gastric cancer
Yuemei Li et al.
OPEN MEDICINE (2018)
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide et al.
CLINICAL CANCER RESEARCH (2018)
Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse
Shenglin Mei et al.
NUCLEIC ACIDS RESEARCH (2017)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF
Kyuho Kang et al.
IMMUNITY (2017)
Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance
Christopher R. Lupfer et al.
JOURNAL OF VIROLOGY (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
NLRC5/CITA: A Key Player in Cancer Immune Surveillance
Sayuri Yoshihama et al.
TRENDS IN CANCER (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling
Sabine Seuter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2017)
NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway
Yun-yun Peng et al.
CANCER LETTERS (2016)
The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin
Susanne V. Schmidt et al.
CELL RESEARCH (2016)
NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
Ann M. Janowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma
Adil I. Daud et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Sayuri Yoshihama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
NLRC5 promotes cell proliferation via regulating the AKT/VEGF-A signaling pathway in hepatocellular carcinoma
Ying-hua He et al.
TOXICOLOGY (2016)
Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair
Timothy Budden et al.
ONCOTARGET (2016)
NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8+ T lymphocytes
Galaxia M. Rodriguez et al.
ONCOIMMUNOLOGY (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Correction: Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Timothy A. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients
Xiaoyu Li et al.
ONCOLOGY LETTERS (2015)
Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information
Kaushala Jayawardana et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Network-based biomarkers enhance classical approaches to prognostic gene expression signatures
Rebecca L. Barter et al.
BMC SYSTEMS BIOLOGY (2014)
MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro
Trevor E. Angell et al.
CLINICAL CANCER RESEARCH (2014)
The N-Terminal Domain of NLRC5 Confers Transcriptional Activity for MHC Class I and II Gene Expression
Andreas Neerincx et al.
JOURNAL OF IMMUNOLOGY (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells
Hiromichi Yuki et al.
BLOOD (2013)
Eukaryotic ribosome biogenesis at a glance
Emma Thomson et al.
JOURNAL OF CELL SCIENCE (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pruning of the Adipocyte Peroxisome Proliferator-Activated Receptor γ Cistrome by Hematopoietic Master Regulator PU.1
Joanna R. DiSpirito et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Sustained PU.1 Levels Balance Cell-Cycle Regulators to Prevent Exhaustion of Adult Hematopoietic Stem Cells
Philipp B. Staber et al.
MOLECULAR CELL (2013)
NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens
Yikun Yao et al.
CELL RESEARCH (2012)
NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner
Andreas Neerincx et al.
JOURNAL OF IMMUNOLOGY (2012)
NLRC5 Deficiency Selectively Impairs MHC Class I-Dependent Lymphocyte Killing by Cytotoxic T Cells
Francesco Staehli et al.
JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: Impaired MHC Class I Expression in Mice Deficient for Nlrc5/Class I Transactivator
Amlan Biswas et al.
JOURNAL OF IMMUNOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
NLRC5: a key regulator of MHC class I-dependent immune responses
Koichi S. Kobayashi et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System
Shereen A. Turkistany et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Cutting Edge: NLRC5-Dependent Activation of the Inflammasome
Beckley K. Davis et al.
JOURNAL OF IMMUNOLOGY (2011)
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
Jun Cui et al.
CELL (2010)
Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
Goran Jonsson et al.
CLINICAL CANCER RESEARCH (2010)
Surprising new roles for PU.1 in the adaptive immune response
Sebastian Carotta et al.
IMMUNOLOGICAL REVIEWS (2010)
Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
Christina Kim et al.
ONCOLOGIST (2010)
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
Torsten B. Meissner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Bo Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
